Pivoting during a pandemic: lessons learned from transitioning a multisite randomized controlled trial to a remote protocol in response to COVID-19 | Zendy

Hailey Inverso | Zendy; Fayo Abadula | Zendy; Troy Morrow | Zendy; Lauren M. LeStourgeon | Zendy; Angelee Parmar | Zendy; Randi Streisand | Zendy; Sarah S. Jaser | Zendy

Open Access

Pivoting during a pandemic: lessons learned from transitioning a multisite randomized controlled trial to a remote protocol in response to COVID-19

Author(s) -

Hailey Inverso,

Fayo Abadula,

Troy Morrow,

Lauren M. LeStourgeon,

Angelee Parmar,

Randi Streisand,

Sarah S. Jaser

Publication year - 2021

Publication title -

translational behavioral medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 39

eISSN - 1869-6716

pISSN - 1613-9860

DOI - 10.1093/tbm/ibab103

Subject(s) - protocol (science) , randomized controlled trial , pandemic , medicine , glycemic , covid-19 , intervention (counseling) , clinical trial , diabetes mellitus , nursing , alternative medicine , pathology , disease , infectious disease (medical specialty) , endocrinology

THR1VE! is an ongoing multisite randomized clinical trial of a positive psychology intervention designed to treat diabetes distress and improve glycemic outcomes in teens with type 1 diabetes. Due to the COVID-19 pandemic restrictions on clinical research and changes in diabetes clinical care, THR1VE! was adapted from an in-person enrollment protocol to a remote protocol through a series of development and testing strategies. We discuss the process of transitioning the protocol and the demonstrated feasibility of ongoing recruitment, enrollment, and retention outcomes. These findings offer support for a remotely transitioned protocol that has larger applications for ongoing and future clinical research.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research